Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Innovative partnerships for drug discovery against neglected diseases.

Jakobsen PH, Wang MW, Nwaka S.

PLoS Negl Trop Dis. 2011 Sep;5(9):e1221. doi: 10.1371/journal.pntd.0001221. Epub 2011 Sep 27. No abstract available.

2.

Progress in public-private partnerships to fight neglected diseases.

Gustavsen K, Hanson C.

Health Aff (Millwood). 2009 Nov-Dec;28(6):1745-9. doi: 10.1377/hlthaff.28.6.1745.

3.

Drugs for neglected diseases: part II.

Kaneko T.

Future Med Chem. 2011 Sep;3(11):1329-30. doi: 10.4155/fmc.11.104. No abstract available.

4.

Interview with Solomon Nwaka.

Nwaka S.

Future Med Chem. 2011 Sep;3(11):1339-44. doi: 10.4155/fmc.11.99.

5.

Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.

Ioset JR, Chang S.

Future Med Chem. 2011 Sep;3(11):1361-71. doi: 10.4155/fmc.11.102.

PMID:
21879842
6.

Drug discovery and development for neglected diseases: the DNDi model.

Chatelain E, Ioset JR.

Drug Des Devel Ther. 2011 Mar 16;5:175-81. doi: 10.2147/DDDT.S16381. Review.

7.

The importance of patent sharing in neglected disease drug discovery.

Edlin C.

Future Med Chem. 2011 Sep;3(11):1331-4. doi: 10.4155/fmc.11.101. No abstract available.

8.

Traditional drug-discovery model ripe for reform.

Cressey D.

Nature. 2011 Mar 3;471(7336):17-8. doi: 10.1038/471017a. No abstract available. Erratum in: Nature. 2011 Mar 10;471(7337):150.

PMID:
21368796
9.

Informatics for neglected diseases collaborations.

Bost F, Jacobs RT, Kowalczyk P.

Curr Opin Drug Discov Devel. 2010 May;13(3):286-96. Review.

PMID:
20443162
10.

Integrated dataset of screening hits against multiple neglected disease pathogens.

Nwaka S, Besson D, Ramirez B, Maes L, Matheeussen A, Bickle Q, Mansour NR, Yousif F, Townson S, Gokool S, Cho-Ngwa F, Samje M, Misra-Bhattacharya S, Murthy PK, Fakorede F, Paris JM, Yeates C, Ridley R, Van Voorhis WC, Geary T.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1412. doi: 10.1371/journal.pntd.0001412. Epub 2011 Dec 20.

11.

Development assistance for neglected tropical diseases: progress since 2009.

Liese BH, Houghton N, Teplitskaya L.

Int Health. 2014 Sep;6(3):162-71. doi: 10.1093/inthealth/ihu052. Epub 2014 Aug 5. Review.

PMID:
25096331
12.

Drug discovery for infectious agents causing neglected diseases.

Silber AM, Pereira CA, Wrenger C.

Curr Med Chem. 2014;21(15):1667. No abstract available.

PMID:
24304273
13.

Tropical disease: A neglected cause.

Laursen L.

Nature. 2016 May 11;533(7602):S68-9. doi: 10.1038/533S68a. No abstract available.

PMID:
27167396
14.

Neglected tropical disease research: rethinking the drug discovery model.

Bombelles T, Coaker H.

Future Med Chem. 2015;7(6):693-700. doi: 10.4155/fmc.15.29. No abstract available.

PMID:
25996062
15.

A kernel for open source drug discovery in tropical diseases.

Ortí L, Carbajo RJ, Pieper U, Eswar N, Maurer SM, Rai AK, Taylor G, Todd MH, Pineda-Lucena A, Sali A, Marti-Renom MA.

PLoS Negl Trop Dis. 2009;3(4):e418. doi: 10.1371/journal.pntd.0000418. Epub 2009 Apr 21.

16.

Control of neglected tropical diseases in Burundi: partnerships, achievements, challenges, and lessons learned after four years of programme implementation.

Ndayishimiye O, Ortu G, Soares Magalhaes RJ, Clements A, Willems J, Whitton J, Lancaster W, Hopkins A, Fenwick A.

PLoS Negl Trop Dis. 2014 May 1;8(5):e2684. doi: 10.1371/journal.pntd.0002684. eCollection 2014 May. No abstract available.

17.

Analysis of neglected tropical disease drug and vaccine development pipelines to predict issuance of FDA priority review vouchers over the next decade.

Stefanakis R, Robertson AS, Ponder EL, Moree M.

PLoS Negl Trop Dis. 2012;6(10):e1803. doi: 10.1371/journal.pntd.0001803. Epub 2012 Oct 25. Review. No abstract available.

18.

The role of product development partnerships in advancing the development of drugs for unmet needs.

Breitstein J, Spigelman M.

Clin Pharmacol Ther. 2013 Jun;93(6):468-70. doi: 10.1038/clpt.2013.53. No abstract available.

PMID:
23689211
19.

Has the NTD community neglected evidence-based policy?

Nagpal S, Sinclair D, Garner P.

PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2238. doi: 10.1371/journal.pntd.0002238. Print 2013. No abstract available.

20.

Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.

Johnston KL, Ford L, Taylor MJ.

J Biomol Screen. 2014 Mar;19(3):335-43. doi: 10.1177/1087057113511270. Epub 2013 Nov 15. Review.

PMID:
24241712
Items per page

Supplemental Content

Write to the Help Desk